Procept Biorobotics
PRCT
116 hedge funds and large institutions have $938M invested in Procept Biorobotics in 2023 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 40 increasing their positions, 33 reducing their positions, and 23 closing their positions.
21% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 33
0.33% more ownership
Funds ownership: 73.23% → 73.56% (+0.33%)
1% less funds holding
Funds holding: 117 → 116 (-1)
4% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 23
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
31% less capital invested
Capital invested by funds: $1.36B → $938M (-$423M)
64% less call options, than puts
Call options by funds: $4.78M | Put options by funds: $13.4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECM
ExodusPoint Capital Management
New York
|
+$12M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$10.6M |
| 3 |
EHI
Eagle Health Investments
Greenwich,
Connecticut
|
+$10M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.42M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$6.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
YU
Yale University
New Haven,
Connecticut
|
-$23.2M |
| 2 |
Millennium Management
New York
|
-$12.4M |
| 3 |
Nuveen
Charlotte,
North Carolina
|
-$7.41M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$6.98M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$6.57M |
PRCT Hedge Fund Activity: Q1 2023 in Review
116 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Procept Biorobotics (PRCT) for Q1 2023, worth a combined $938M — down 31% from $1.36B a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of PRCT and 22 opened new positions — a net loss of 1 holder — while 33 trimmed existing stakes and 40 added.
The largest buyer was ExodusPoint Capital Management, opening a new position worth an estimated $12M. The largest seller was Yale University, exiting entirely with an estimated $23.2M sold.
- 116 institutional investors held Procept Biorobotics (PRCT) as of Q1 2023, down from 117 in Q4 2022.
- Funds reported $938M of Procept Biorobotics stock for Q1 2023, down 31% quarter-over-quarter.
- 22 funds opened new Procept Biorobotics positions in Q1 2023 and 23 closed out, a net change of -1 holder.
- The largest Procept Biorobotics buyer in Q1 2023 was ExodusPoint Capital Management, an estimated $12M added.
- The largest Procept Biorobotics seller in Q1 2023 was Yale University, an estimated $23.2M sold.
Based on aggregated 13F filings for Q1 2023.